Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer&#39;s disease.

AL002 - Alector, AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/39444037

Adam Simmons; Anna Rychkova; Arnon Rosenthal; Arthur Mayorga; Balasubrahmanyam Budda; Brady Burgess; Felix Yeh; Herve Rhinn; Hua Long; Ilaria Tassi; Michael Ward; Robert Paul; Sara Kenkare-Mitra; Tina Schwabe; Tuan Nguyen

Oct 24, 2024